In brief: Cellular model tracks evolution of AML; Trial identifies optimum time to review patients on warfarin; Fibrinogen has an anti-inflammatory role

Cellular model tracks the evolution of leukaemia Scientists have built the first cellular model to depict the evolution of acute myeloid leukaemia, from its early to late stages using gene editing technology. Using CRISPR gene editing the researchers altered DNA sequences in induced pluripotent stem cells to create a model that showed progressive malignant features ...

Already a member?

Login to keep reading.

© 2021 the limbic